Equivalence testing and equivalence limits of metered-dose inhalers and dry powder inhalers measured by in vitro impaction

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 49, Issue 3, 2000, Pages 295-302

  Weda, Marjolein ^a   Geuns, Eduard R M ^a   Vermeer, Raymond C R ^a   Buiten, Nathalie R A ^a   Hendriks De Jong, Kirsten ^a   Bult, Auke ^b   Zanen, Pieter ^c   Barends, Dirk M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Heart Lung Center Utrecht   (Netherlands)

Author keywords

Dry powder inhalers; Equivalence; Impaction; Metered dose inhalers; Twin Impinger

Indexed keywords

BECLOMETASONE DIPROPIONATE; SALBUTAMOL;

ARTICLE; BIOEQUIVALENCE; DRY POWDER; IN VITRO STUDY; INHALER; MATERIALS TESTING; METERED DOSE INHALER; TECHNIQUE;

ALBUTEROL; ANTI-ASTHMATIC AGENTS; BECLOMETHASONE; BRONCHODILATOR AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; NEBULIZERS AND VAPORIZERS; POWDERS; THERAPEUTIC EQUIVALENCY;

EID: 0034595203     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(00)00064-3     Document Type: Article

References (20)

1. The European Agency for the Evaluation of Medicinal Products, London, CPMP note for guidance on investigation of bioavailability and bioequivalence, 1992.
2. Snell N.J.C. Assessing equivalence of inhaled products. J. Pharm. Pharmacol. 49 (Suppl 3):1997;55-60.
3. Zanen P., Lammers J.-W.J. Sample sizes for comparative inhaled corticosteroid trials with emphasis on showing therapeutic equivalence. Eur. J. Clin. Pharmacol. 48:1995;179-184.
4. The European Agency for the Evaluation of Medicinal Products, London, CPMP Note for guidance on replacement of chlorofluorocarbons (CFC's) in metered dose inhalation products, 1993.
5. The European Agency for the Evaluation of Medicinal Products, London, CPMP note for guidance on clinical requirements for locally-applied, locally-acting products containing known constituents, 1995.
6. Aswania O.A., Corlett S.A., Chrystyn H. Determination of the relative bioavailability of nedocromil sodium to the lung following inhalation using urinary excretion. Br. J. Clin. Pharmacol. 54:1998;475-478.
7. ® is twice that from a pressurized metered-dose inhaler (p-MDI). Eur. Respir. J. 7:1994;1839-1844.
8. Pauwels R., Newman S., Borgström L. Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers. Eur. Respir. J. 10:1997;2127-2138.
9. Newnhamd D., McDevitt D., Lipworth B. Comparison of the extrapulmonary beta2-adrenoreceptor responses and the pharmacokinetics of salbutamol given by standard metered-dose inhaler and modified actuator device. Br. J. Clin. Pharmacol. 36:1993;445-450.
10. European Pharmacopoeia Convention, Council of Europe, European Pharmacopoeia, second ed., V.5.9.1., 1995.
11. Croes K., McCarthy P.T., Flanagan R.J. HPLC of basic drugs and quaternary ammonium compounds on microparticulate strong cation-exchange materials using methanolic or aqueous methanol eluents containing an ionic modifier. J. Chromatogr. 693:1995;289-306.
12. Martinez N., Iglewicz B. A test for departure from normality based on a biweight estimator of scale. Biometrika. 68:1981;331-333.
13. Caulcutt R., Boddy R. Statistics for Aanalytical Chemists. 1983;70 Chapman and Hall, London.
14. Caulcutt R., Boddy R. Statistics for Analytical Chemists. 1983;72 Chapman and Hall, London.
15. The British Pharmacopoeia Commission, London, UK, British Pharmacopoeia, 1993, p. 1408.
16. The British Pharmacopoeia Commission, London, UK, British Pharmacopoeia, 1993, p. 2083.
17. Bauer K., Sertl K., Kaik B., Kaik G. Effect of solution and suspension type aerosol of formoterol on tremor, response and airways in patients with asthma. J. Allergy Clin. Immunol. 96:1995;495-501.
18. Borgström L., Asking L., Beckman O., Bondesson E., Källén A., Olsson B. Discrepancy between in vitro and in vivo dose variability for a pressurized metered-dose inhaler and a dry powder inhaler. J. Aerosol Med. 11 (Suppl 1):1998;S59-S64.
19. Ayres J.G., Benincasa C. Acute bronchoconstriction following use of salmeterol xinafoate via the metered-dose inhaler in adult asthmatics. Am. Rev. Respir. Dis. 147:1993;A61.
20. Clark D.J., Lipworth B.J. Dose-response of inhaled drugs in asthma, an update. Clin. Pharmacokinet. 32:1997;58-74.